Association of cd1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: A cytologic and immunocytochemical evaluation

Cancer Cytopathology

Volumn 121, Issue 4, 2013, Pages 206-213

  Pusztaszeri, Marc P ^a   Sadow, Peter M ^b,c   Faquin, William C ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CD1a; Cytopathology; Dendritic cells; Fine needle aspiration; Immunohistochemistry; Langerhans cells; Papillary carcinoma; Thyroid

Indexed keywords

LANGERIN; T6 ANTIGEN; CD1 ANTIGEN; CELL SURFACE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; DENDRITIC CELL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID NODULE; THYROID PAPILLARY CARCINOMA; CELL DIFFERENTIATION; CYTODIAGNOSIS; ENZYME IMMUNOASSAY; GENETICS; IMMUNOLOGY; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; THYROID GLAND; THYROID TUMOR; VERY ELDERLY; CELL ISOLATION; CELL SURFACE; CYTOLOGY; CYTOPLASM; LANGERHANS CELL; MAJOR CLINICAL STUDY; THYMOCYTE; THYROID CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD1; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; CYTODIAGNOSIS; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84878430080     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21239     Document Type: Article

References (45)

1. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 1997;9:10-16.
2. Hart DN. Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood. 1997;90:3245-3287.
3. Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med. 1999;190:1417-1426.
4. Banchereau J, Steinman RM. Dendritic cells and control of immunity. Nature. 1998;392:245-252.
5. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811.
6. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327:656-661.
7. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol. 2008;8:935-947.
8. Birbeck MS, Breathnach AS, Everall JD. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol. 1961;37:51-64.
9. Valladeau J, Ravel O, Dezutter-Dambuyant C, et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity. 2000;12:71-81.
10. Valladeau J, Duvert-Frances V, Pin JJ, et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol. 1999;29:2695-2704.
11. Dezutter-Dambuyant C, Schmitt D, Staquet MJ, Gaucherand M, Cambazard F, Thivolet J. DMC1: A monoclonal antibody produced from histiocytosis X cells which reacts with the native CD1a molecule of human epidermal Langerhans cells. Hybridoma. 1989;8:199-208.
12. Coventry B, Heinzel S. CD1a in human cancers: A new role for an old molecule. Trends Immunol. 2004;25:242-248.
13. Tsuge K, Takeda H, Kawada S, Maeda K, Yamakawa M. Characterization of dendritic cells in differentiated thyroid cancer. J Pathol. 2005;205:565-576.
14. Greaves DR, Wang W, Dairaghi DJ, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med. 1997;186:837-844.
15. De Saint-Vis B, Vincent J, Vandenabeele S, et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity. 1998;9:325-336.
16. Sorg UR, Morse TM, Patton WN, et al. Hodgkin's cells express CD83, a dendritic cell lineage associated antigen. Pathology. 1997; 29:294-299.
17. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 1995;154:3821-3835.
18. Geijtenbeek TB, Torensma R, van Vliet SJ, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575-585.
19. Kabel PJ, Voorbij HA, De Haan M, van der Gaag RD, Drexhage HA. Intrathyroidal dendritic cells. Clin Endocrinol Metab. 1988;66:199-207.
20. Wischatta M, Brunhuber T, Neher A, et al. Phenotypic characterization and distribution of dendritic cells in parotid gland tumors. ORL J Otorhinolaryngol Relat Spec. 2004;66:313-319.
21. Schwaab T, Weiss JE, Schned AR, Barth RJ Jr. Dendritic cell infiltration in colon cancer. J Immunother. 2001;24:130-137.
22. Ladanyi A, Kiss J, Somlai B, et al. Density of DC-LAMP(?) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother. 2007;56:1459-1469.
23. Perez L, Shurin MR, Collins B, Kogan D, Tourkova IL, Shurin GV. Comparative analysis of CD1a, S-100, CD83, and CD11c human dendritic cells in normal, premalignant, and malignant tissues. Histol Histopathol. 2005;20:1165-1172.
24. Bergeron A, El-Hage F, Kambouchner M, Lecossier D, Tazi A. Characterisation of dendritic cell subsets in lung cancer micro-environments. Eur Respir J. 2006;28:1170-1177.
25. Karthaus N, Torensma R, Tel J. Deciphering the message broadcast by tumor-infiltrating dendritic cells. Am J Pathol. 2012;181:733-742.
26. Xu W, Li X, Chen S, et al. Expression and distribution of S-100, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in tissues of thyroid carcinoma. Eur J Histochem. 2008;52:153-162.
27. Ugolini C, Basolo F, Proietti A, et al. Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma. Thyroid. 2007;17:389-393.
28. Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol. 1988;89:295-300.
29. Yamakawa M, Yamada K, Orui H, et al. Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas. Anal Cell Pathol. 1995;8:331-343.
30. Yamakawa M, Kato H, Takagi S, Karube Y, Seki K, Imai Y. Dendritic cells in various human thyroid diseases. In Vivo. 1993;7:249-256.
31. Batistatou A, Zolota V, Scopa CD. S-100 protein? dendritic cells and CD34? dendritic interstitial cells in thyroid lesions. Endocr Pathol. 2002;13:111-115.
32. Sandel MH, Dadabayev AR, Menon AG, et al. Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: Role of maturation status and intratumoral localization. Clin Cancer Res. 2005;11:2576-2582.
33. Goldman SA, Baker E, Weyant RJ, Clarke MR, Myers JN, Lotze MT. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg. 1998;124:641-646.
34. Ma Y, Xian M, Li J, Kawabata T, Okada S. Interrelations of clinicopathological variables, local immune response and prognosis in esophageal squamous cell carcinoma. APMIS. 1999;107:514-522.
35. Renshaw AA. "Histiocytoid" cells in fine-needle aspirations of papillary carcinoma of the thyroid: Frequency and significance of an under-recognized cytologic pattern. Cancer (Cancer Cytopathol). 2002;96:240-243.
36. Harshan M, Crapanzano JP, Aslan DL, Vazquez MF, Saqi A. Papillary thyroid carcinoma with atypical histiocytoid cells on fine-needle aspiration. Diagn Cytopathol. 2009;37:244-250.
37. Proietti A, Ugolini C, Melillo RM, et al. Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: Correlation with clinical and pathological parameters. Thyroid. 2011;21:1209-1215.
38. Almand B, Resser JR, Lindman B, et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res. 2000;6:1755-1766.
39. Gabrilovich D. Mechanisms and functional significance of tumourinduced dendritic cell defects. Nat Rev Immunol. 2004;4:941-952.
40. Gabrilovich DI, Ciernik F, Carbone DP. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumorbearing hosts. Cell Immunol. 1996;170:101-110.
41. Enk AH, Jonuleit H, Saloga J, Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer. 1997;73:309-316.
42. Chaux P, Moutet M, Faivre J, Martin F, Martin M. Inflammatory cells infiltrating human colorectal arcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab Invest. 1996;74:975-983.
43. Shimabukuro-Vornhagen A, Draube A, Liebig TM, Rothe A, Kochanek M, von Bergwelt-Baildon MS. The immunosuppressive factors IL-10, TGF-beta, and VEGF do not affect the antigen-presenting function of CD40-activated B cells [serial online]. J Exp Clin Cancer Res. 2012;31:47.
44. Steinbrink K, Jonuleit H, Muller G, Schuler G, Knop J, Enk AH. Interleukin-10-treated human dendritic cells induce a melanomaantigen-specific anergy in CD8(?) T cells resulting in a failure to lyse tumor cells. Blood. 1999;93:1634-1642.
45. Lutz M, Schuler G. Immature, semimature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol. 2002;23:445-449.